🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

By incorporating #RSV consequences into economic assessments, we can improve decision-making and enhance national responses. 💶 Delve into this and other insights from Prof. Dr. med. Monika Gappa, from the ERS: imi-promise.eu/dissemination/…

Dr. Edoardo Colzani calls for more research and better surveillance to combat RSV, especially in older adults. With RSV on track to become a notifiable disease in the EU, we're at a critical juncture. 🏥 Discover the full debate, here: loom.ly/_0rgIAU Innovative Health Initiative

European #RSV Surveillance Bulletin #10⤵ “Austria, Denmark, France and the Netherlands reported that the trend in percentage of RSV positive cases is decreasing. The trend in percentage of RSV positive cases remains stable in Slovenia.” 👉imi-promise.eu/surveillance/p…

#RSV is now preventable. Member States must act to get prevention tools where they're needed most. Let's tackle this together. 🩺🇪🇺 Watch the full webinar: imi-promise.eu/dissemination/… @ihieurope Sanofi Teamit Federico Martinón-Torres

At the PROMISE webinar, the call for action was clear: adopting #RSV prevention strategies is a moral duty. Our healthcare must protect the most vulnerable - infants and the elderly. 🛡️ 💬 Explore the full debate: loom.ly/_0rgIAU Innovative Health Initiative Sanofi Teamit

The path to combatting Respiratory Syncytial Virus (#RSV) lies in highlighting the importance of vaccination to our policymakers. Investing in RSV vaccines is not just a measure of immediate protection but a long-term strategy to safeguard us all. 🏘️ ℹ️: loom.ly/_0rgIAU

Dr.Edoardo Colzani highlights the urgent need for more Respiratory Syncytial Virus research and better surveillance for older adults. With #RSV set to become notifiable disease in the EU, it's time for action. 🛡️ Watch the full webinar here:loom.ly/_0rgIAU Innovative Health Initiative

Our focus always remained clear: to develop innovative immunisation tools and therapeutics to combat this potentially deadly virus, especially in our paediatric and elderly populations👶👵 Thank you everyone for your support & participation to date! Innovative Health Initiative

PROMISE Project European hashtag #RSV Surveillance Bulletin #12⤵ “In week 12, Slovenia reported RSV activity. Austria, France and Portugal reported sporadic RSV activity. Belgium, Denmark and the Netherlands reported baseline RSV activity.” 👉imi-promise.eu/surveillance/p…

PROMISE Project European hashtag #RSV Surveillance Bulletin #14⤵ “In reporting week 14 Austria, France and Portugal and Slovenia reported sporadic RSV activity. Belgium, Denmark and the Netherlands reported baseline RSV activity.” Full bulletin here 👉imi-promise.eu/surveillance/p…

PROMISE Project European hashtag #RSV Surveillance Bulletin #16⤵ “France, Portugal and Slovenia reported sporadic RSV activity. Austria, Belgium and the Netherlands reported baseline RSV activity.” Full bulletin here 🔗imi-promise.eu/surveillance/p…

📢 New deliverable out! 👉 D1.1 Report on novel clinical scores for RSV severity 🔗 loom.ly/jpT7xxk #PROMISE #RSV #RSVPatientNetwork Charlotte Vernhes Innovative Health Initiative ReSViNET John Paget, PhD

📢 New deliverable out! 👉 D1.2 Report on variation in global RSV seasonality by subtypes 🔗 loom.ly/7QS9wZk #PROMISE #RSV #RSVPatientNetwork Charlotte Vernhes Innovative Health Initiative ReSViNET John Paget, PhD

📢 New deliverable out! 👉 D1.3 Report on RSV burden in pregnant women 🔗 loom.ly/YIKIAoo #PROMISE #RSV #RSVPatientNetwork Charlotte Vernhes Innovative Health Initiative ReSViNET John Paget, PhD

📢 New deliverable out! 👉D1.5 Report on global impact of COVID-19 on RSV burden 🔗 loom.ly/lbimvZw #PROMISE #RSV #RSVPatientNetwork Charlotte Vernhes Innovative Health Initiative ReSViNET John Paget, PhD

📢 New deliverable out! 👉D2.8 Identification of methodological challenges 🔗loom.ly/_WjRoNY #PROMISE #RSV #RSVPatientNetwork Charlotte Vernhes Innovative Health Initiative ReSViNET John Paget, PhD

📢 New deliverable out! 👉D2.4 Report on identification of adverse events for safety evaluations of RSV vaccination and monoclonal antibodies 🔗loom.ly/r8UCJOE #PROMISE #RSV #RSVPatientNetwork Charlotte Vernhes Innovative Health Initiative ReSViNET John Paget, PhD

📢 New deliverable out! 👉D2.12 Final Progress Report Task 2.2 🔗loom.ly/7VgoMbs #PROMISE #RSV #RSVPatientNetwork Charlotte Vernhes Innovative Health Initiative ReSViNET John Paget, PhD